Clostridium difficile infections in animals with special reference to the horse. A review

Veterinary Quarterly

Volumn 24, Issue 4, 2002, Pages 203-219

  Baverud V ^a  

^a NATIONAL VETERINARY INSTITUTE   (Sweden)

Author keywords

Antibiotic associated diarrhea; Bacterial diseases; Clostridum difficile infections; Colitis; Diarrhea; Horse Diseases; Intestinal diseases

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPICILLIN; ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; BACTERIAL TOXIN; BETA LACTAM ANTIBIOTIC; CEFOXITIN; CEFTIOFUR; CHLORAMPHENICOL; CLINDAMYCIN; CLOSTRIDIUM DIFFICILE TOXIN A; CLOSTRIDIUM DIFFICILE TOXIN B; COTRIMAZINE; CYCLOSERINE; CYTOTOXIN; ERYTHROMYCIN; GENTAMICIN; HYPOCHLORITE; IMMUNOGLOBULIN G; LINCOMYCIN; LINCOSAMIDE; MACROLIDE; METRONIDAZOLE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; RIFAMPICIN; SULFONAMIDE; TETRACYCLINE DERIVATIVE; TRIMETHOPRIM; UNINDEXED DRUG; VANCOMYCIN;

ACUTE DISEASE; ANIMAL DISEASE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; BACTERIAL COLONIZATION; BACTERIAL PNEUMONIA; BACTERIAL SUPERINFECTION; BACTERIUM ISOLATION; CLOSTRIDIUM DIFFICILE; COLITIS; DIARRHEA; DISEASE SEVERITY; DRUG INDUCED DISEASE; DRUG METABOLISM; FEMALE; HORSE; INTESTINE INFECTION; LABORATORY DIAGNOSIS; MALE; NEWBORN; NONHUMAN; PATHOGENESIS; REVIEW; RHODOCOCCUS EQUI; SYMPTOMATOLOGY; TAXONOMY;

ANIMALIA; BACTERIA (MICROORGANISMS); CLOSTRIDIA; CLOSTRIDIUM; CLOSTRIDIUM DIFFICILE; CORYNEBACTERIUM; EQUIDAE; EQUUS CABALLUS; RHODOCOCCUS; RHODOCOCCUS EQUI;

EID: 0036962371     PISSN: 01652176     EISSN: None     Source Type: Journal    
DOI: 10.1080/01652176.2002.9695137     Document Type: Article

References (181)

1. Alcantara CS and Guerrant RL. Update on Clostridium difficile infection. Current Gastroenterology Reports 2000; 2: 310-314.
2. Al Saif N and Brazier JS. The distribution of Clostridium difficile in the environment of South Wales. Journal of Medical Microbiology 1996; 45: 133-137.
3. Andersson G, Ekman L, Månsson I, Persson S, Rubarth S and Tufvesson G. Lethal complications following administration of oxytetracycline in the horse. Nordisk Veterinärmedicin 1971; 23: 9-22.
4. Aronsson B, Möllby R and Nord CE. Occurrence of toxin-producing Clostridium difficile in antibiotic-associated diarrhea in Sweden. Medical Microbiology and Immunology 1981; 170: 27-35.
5. Aronsson B, Möllby R and Nord CE. Antimicrobial agents and Clostridium difficile in acute enteric disease: epidemiological data from Sweden, 1980-1982. Journal of Infectious Diseases 1985; 151: 476-481.
6. Arzese A, Trani G, Riul L and Botta GA. Rapid polymerase chain reaction method for specific detection of toxigenic Clostridium difficile. European Journal of Clinical Microbiology and Infectious Diseases 1995; 14: 716-719.
7. Barbut F and Petit J-C. Epidemiology of Clostridium difficile-associated infections. Clinical Microbiology and Infection 2001; 7: 405-410.
8. Bartlett JG. Clostridium difficile: Clinical considerations. Reviews of Infectious Diseases 1990; 12: (suppl. 2) 243-251.
9. Bartlett JG, Onderdonk AB, Cisneros RL and Kasper DL. Clindamycin associated colitis due to a toxin-producing species of Clostridium in hamsters. Journal of Infectious Diseases 1977; 136: 701-705.
10. Bartlett JG, Chang TW, Gurwith M, Gorbach SL and Onderdonk AB. Antibiotic-associated pseudomembranous colitis due to toxin-producing clostridia. New England Journal of Medicine 1978; 298: 531-534.
11. Bartley SL and Dowell VR Jr. Comparison of media for the isolation of Clostridium difficile from faecal specimens. Laboratory Medicine 1991; 22: 335-338.
12. Båverud V. Clostridium difficile in Horses. Doctoral thesis, Swedish University of Agricultural Sciences, 2002. ISSN 1401-6257, ISBN 91-576-6378-5.
13. Båverud V, Gustafsson A, Franklin A, Lindholm A and Gunnarsson A. Clostridium difficile associated with acute colitis in adult horses treated with antibiotics. Equine Veterinary Journal 1997; 29: 279-284.
14. Båverud V, Franklin A, Gunnarsson A, Gustafsson A, and Hellander-Edman A. Clostridium difficile associated with acute colitis in mares when their foals are treated with erythromycin and rifampicin for Rhodococcus equi pneumonia. Equine Veterinary Journal 1998; 30: 482-488.
15. Båverud V, Gustafsson A, Franklin A, Aspán A and Gunnarsson A. Clostridium difficile: prevalence in horses, in environment and antimicrobial susceptibility. Equine Veterinary Journal, in press.
16. Beier R, Amtsberg G and Peters M. Bakteriologische Untersuchungen zum Vorkommen und zur Bedeutung von Clostridium difficile beim Pferd. Pferdeheilkunde 1994; 10: 3-8.
17. Bergey's Manual Trust, Department of Microbiology and Molecular Genetics, Michigan State University, East Lansing, Michigan, USA. (http://www.cme.msu.edu/Bergeys/, accessed May 2, 2002).
18. Berry AP and Levett PN. Chronic diarrhoea in dogs associated with Clostridium difficile infection. Veterinary Record 1986; 118: 102-103.
19. Bidet P, Barbut F, Lalande V, Burghoffer B and Petit J-C. Development of a new PCR-ribotyping method for Clostridium difficile based on ribosomal RNA gene sequencing. FEMS Microbiology Letters 1999; 175: 261-266.
20. Blawat F and Chylinski G. Pathogenic clostridia in soil and faeces of domestic animals, in the Gdansk region. Bulletin of the Institute of Marine Medicine in Gdansk 1958; 9: 117-126.
21. Borriello SP. Pathogenesis of Clostridium difficile infection. Journal of Antimicrobial Chemotherapy 1998; 41: Suppl. C, 13-19.
22. Borriello SP and Honour P. Simplified procedure for the routine isolation of Clostridium difficile from faeces. Journal of Clinical Pathology 1981; 34: 1124-1127.
23. Borriello SP, Honour P, Turner T and Barclay F. Household pets as a potential reservoir for Clostridium difficile infection. Journal of Clinical Pathology 1983; 36: 84-87.
24. Bowman RA and Riley TV. isolation of Clostridium difficile from stored specimens and comparative susceptibility of various tissue culture cell lines to cytotoxin. FEMS Microbiology Letters 1986; 34: 31-35.
25. Braun V, Hundsberger T, Leukel P, Sauerborn M and von Eichel-Streiber C. Definition of the single integration site of the pathogenicity locus in Clostridium difficile. Gene 1996; 181: 29-38.
26. Braun M, Herholz C, Straub R, Choisat B, Frey J, Nicolet J and Kuhnert P. Detection of the ADP-ribosyltransferase toxin gene (cdtA) and its activity in Clostridium difficile isolates from equidae. FEMS Microbiology Letters 2000; 184: 29-33.
27. Brazier JS. The epidemiology and typing of Clostridium difficile. Journal of Antimicrobial Chemotherapy 1998; 41: Suppl. C, 47-57.
28. Brazier JS. Typing of Clostridium difficile. Clinical Microbiology and Infection 2001; 7: 428-431.
29. Brazier JS and Borriello SP. Microbiology, epidemiology and diagnosis of Clostridium difficile infection. In: Clostridium docile. 1st edn. Eds. K. Aktories and T.D. Wilkins. Springer, Berlin, 2000. pp.1-33.
30. Brooks GF, Butel JS, Ornston LN, Jawetz E, Melnick JL and Adelberg EA. Cell Structure. In: Jawetz, Melnick and Adelberg's Medical Microbiology. 19th edn. Prentice Hall International Limited. London, 1991. pp. 7-31.
31. Buchanan AG. Selective enrichment broth culture for detection of Clostridium difficile and associated cytoxin. Journal of Clinical Microbiology 1984; 20: 74-76.
32. Buggy BP, Wilson KH and Fekety R. Comparison of methods for recovery of Clostridium difficile from an environmental source. Journal of Clinical Microbiology 1983; 18: 348-352.
33. Buogo C, Burnens AP, Perrin J and Nicolet J. Presence of Campylobacter spp., Clostridium difficile, C. perfringens and Salmonella in some litters and in a kennel population of adult dogs. Schweizer Archiv für Tierheilkunde 1995; 137: 165-171.
34. Carter GR, Chengappa MM and Roberts AW. Clostridium. In: Essentials of Veterinary Microbiology. 5th edn. Ed. C. Cann. Williams and Wilkins, Baltimore, 1995. pp. 134-141.
35. AL In: Bergey's Manual of Systematic Bacteriology, Volume 2. 1st edn. Eds. P.H.A. Sneath, N.S. Mair, M.E. Sharpe and J.G. Holt. Williams and Wilkins, Baltimore, MD, 1986. pp. 1141-1142.
36. Chang T-W, Bartlett JG, Gorbach SL and Onderdonk AB. Clindamycin-induced enterocolitis in hamsters as a model of pseudomembranous colitis in patients. Infection and Immunity 1978; 20: 526-529.
37. Cleary RK. Clostridium difficile-associated diarrhea and colitis. Clinical manifestations, diagnosis and treatment. Diseases of the Colon and Rectum 1998; 41: 1435-1449.
38. Cohen ND and Woods AM. Characteristics and risk factors for failure of horses with acute diarrhea to survive: 122 cases (1990-1996). Journal of the American Veterinary Medical Association 1999; 214: 382-390.
39. Collins MD, Lawson PA, Willems A, Cordoba JJ, Fernandez-Garayzabal J, Garcia P, Cai J, Hippe H and Farrow JAE. The phylogeny of the genus Clostridium: Proposal of five new gerera and eleven new species combinations. International Journal of Systematic Bacteriology 1994; 44: 812-826.
40. Cosmetatos I, Perrin J, Gallusser A, Nicolet J and Straub R. Faecal isolation of Clostridium difficile and its toxins from horses with typhlo-colitis. 7th Intern. Conference on Equine Infectious Diseases, June 8-11, 1994, Tokyo, Japan. Poster session 69.
41. Delmée M. Laboratory diagnosis of Clostridium difficile disease. Clinical Microbiology and Infection 2001; 7: 411-416.
42. Delmée M, Homel M and Wauters G. Serogrouping of Clostridium difficile strains by slide agglutination. Journal of Clinical Microbiology 1985; 21: 323-327.
43. Delmée M and Avesani V. Correlation between serogroup and susceptibility to chloramphenicol, clindamycin, erythromycin, rifampicin and tetracycline among 308 isolates of Clostridium difficile. Journal of Antimicrobial Chemotherapy 1988; 22: 325-331.
44. Divers TJ. Postoperative complications-colitis, Clostridial diarrhea in adult horses, Acute diarrhea in adult horses-other causes, Clostridial enterocolitis in foals. In: Manual of Equine Gastroenterology. 1st edn. Eds. T. Mair, T. Divers and N. Ducharme. WB Saunders, 2002. pp. 230-232, 410-412, 422-425, 499-502.
45. Donaldson MT and Palmer JE. Prevalence of Clostridium perfringens enterotoxin and Clostridium docile toxin A in faeces of horses with diarrhea and colic. Journal of the American Veterinary Medical Association 1999; 3: 358-361.
46. Ehrich M, Perry BD, Troutt F, Dellers RW and Magnusson RA. Acute diarrhea in horses of the Potomac River area: Examination for clostridial toxins. Journal of the American Veterinary Medical Association 1984; 185: 433-435.
47. Eld K, Gunnarsson A, Holmberg T, Hurvell B and Wierup M. Salmonella isolated from animals and feedstuffs in Sweden during 1983-1987. Acta Veterinaria Scandinavica 1991; 32: 261-277.
48. Ensink JM. Side effects of oral antimicrobial agents in the horse; a comparison of pivampicillin and trimethoprim-sulfadiazine. Veterinary Record 1996; 138: 253-256.
49. Farrell RJ and LaMont JT. Pathogenesis and clinical manifestations of Clostridium difficile diarrhea and colitis. In: Clostridium difficile. 1st edn. Eds. K. Aktories and T.D. Wilkins. Springer, Berlin, 2000. pp. 109-125.
50. Fekety R. Antibiotic-associated diarrhea and colitis. Current Opinion of Infectious Diseases 1995; 8: 391-397.
51. Fekety R, Silva J, Toshniwal R, Allo M, Armstrong J, Browne R, Ebright J and Rifkin G. Antibiotic-associated colitis: Effects of antibiotics on Clostridium difficile and the disease in hamsters. Reviews of Infectious Diseases 1979; 1: 386-397.
52. Fekety R, Kim K-H, Brown D, Batts DH, Cudmore M and Silva J Jr. Epidemiology of antibiotic-associated colitis. Isolation of Clostridium difficile from the hospital environment. American Journal of Medicine 1981; 70: 906-908.
53. Fekety R and Shah AB. Diagnosis and treatment of Clostridium difficile colitis. Journal of the American Medical Association 1993; 269: 71-75.
54. Frazier KS, Herron AJ, Hines II ME, Gaskin JM and Altman NH. Diagnosis of enteritis and enterotoxemia due to Clostridium difficile in captive ostriches (Struthio camelus). Journal of Veterinary Diagnostic Investigation 1993; 5: 623-625.
55. Frost F, Craun GF and Calderon RL. Increasing hospitalization and death possibly due to Clostridium difficile diarrheal disease. Emerging Infectious Diseases 1998; 4: 619-625.
56. George RH and Symonds JM. Identification of Clostridium difficile as a cause of pseudomembranous colitis. British Medical Journal 1978; 1: 695.
57. George WL, Sutter VL, Goldstein EJ, Ludwig SL and Finegold SM. Aetiology of antimicrobial-agent-associated colitis. Lancet i, 1978; 802-803.
58. George WL, Sutter VL, Citron D and Finegold SM. Selective and differential medium for isolation of Clostridium difficile. Journal of Clinical Microbiology 1979; 9: 214-219.
59. George WL, Kirby BD, Sutter VL and Finegold SM. Antimicrobial susceptibility of Clostridium difficile. Microbiology (Wash., D.C.) 1979; 267-271.
60. Gottschalk G, Andreesen JR and Hippe H. The genus Clostridium. In: The Prokaryotes, a handbook on the habitats, isolation and identification of bacteria. Eds. Starr, Stolp, Trüper, Balows and Schlegel. Springer-Verlag, Berlin, 1981. pp. 1767-1803.
61. Green RH. The association of viral activation with penicillin toxicity in guinea pigs and hamsters. Yale Journal of Biology and Medicine 1974; 3: 166-181.
62. Gumerlock PH, Tang YJ, Weiss JB and Silva J. Specific detection of toxigenic strains of Clostridium difficile in stool specimens. Journal of Clinical Microbiology 1993; 31: 507-511.
63. Gustafsson A, Båverud V, Gunnarsson A, Horn af Rantzien M, Lindholm A and Franklin A. The association of erythromycin ethylsuccinate with acute colitis in horses in Sweden. Equine Veterinary Journal 1997; 29: 314-318.
64. Hafiz S. Clostridium difficile and its toxins. Doctoral thesis, Department of Microbiology, University of Leeds, 1974.
65. Hafiz S and Oakley CL. Clostridium difficile: isolation and characteristics. Journal of Medical Microbiology 1976; 9: 129-136.
66. Hall IC and O'Toole E. Intestinal flora in newborn infants with a description of a new pathogenic anaerobe, Bacillus difficilis. American Journal of Diseases of Children 1935; 49: 390-402.
67. Hecht G, Koutsouris A, Pothoulakis C, LaMont JT and Madara JL. Clostridium difficile toxin B disrupts the barrier function of T84 monolayers, Gastroenterology 1992; 102: 416-423.
68. Herholz C, Miserez R, Nicolet J, Frey J, Popoff M, Gibert M, Gerber H and Straub R. Prevalence of β2-toxigenic Clostridium perfringens in horses with intestinal disorders. Journal of Clinical Microbiology 1999; 37: 358-361.
69. Hibbs CM, Johnson DR, Reynolds K and Harrington R Jr. Clostridium sordellii isolated from foals. Veterinary Medicine, Small Animal Clinician 1977; 72: 256-258.
70. Jang SS, Hansen LM, Breher JE, Riley DA, Magdesian KG, Madigan JE, Tang YJ, Silva JR J and Hirsh DC. Antimicrobial susceptibilities of equine isolates of Clostridium difficile and molecular characterization of metronidazole-resistant strains. Clinical Infectious Diseases 1997; 25: (Suppl 2): S266-267.
71. Job M and Jacobs N. Drug-induced Clostridium difficile-associated disease. Drug Safety 1997; 17: 37-46.
72. Johnson JL and Francis BS. Taxonomy of the Clostridia: Ribosomal ribonucleic acid homologies among the species. Journal of General Microbiology 1975; 88: 229-244.
73. Johnson S, Samore MH, Farrow KA, Killgore GE, Tenover FC, Lyras D, Rood JI, DeGirolami P, Baltch AL, Rafferty ME, Pear SM and Gerding DN, Epidemics of diarrhea caused by a clindamycin-resistant strain of Clostridium difficile in four hospitals. New England Journal of Medicine 1999; 341: 1645-1651.
74. Jones RL. Clostridial enterocolitis. Veterinary Clinics of North America. Equine Practice 2000; 16: 471-485.
75. Jones RL, Adney WS and Shideler RK. Isolation of Clostridium difficile and detection of cytotoxin in the feces of diarrheic foals in the absence of antimicrobial treatment. Journal of Clinical Microbiology 1987; 25: 1225-1227.
76. Jones RL, Adney WS, Alexander AF, Shideler RK and Traub-Dargatz JL. Hemorrhagic necrotizing enterocolitis associated with Clostridium difficile infection in four foals. Journal of the American Veterinary Medical Association 1988; 193: 76-79.
77. Jones RL, Shideler RK and Cockerell GL. Association of Clostridium difficile with foal diarrhea. In: Proc. 5th International Conference on Equine Infectious Diseases, Lexington, Kentucky. University Press of Kentucky, Lexington, 1988. pp. 236-240.
78. Jones RL. Diagnostic procedures for isolation and characterization of Clostridium difficile associated with enterocolitis in foals. Journal of Veterinary Diagnostic Investigation 1989; 1: 84-86.
79. Jones SL and Wilson WD. Clostridium septicum septicemia in a neonatal foal with hemorrhagic enteritis. Cornell Veterinarian 1993; 83: 143-151.
80. Jukes T H and Cantor C R. Evolution of protein molecules. In: Mammalian Protein Metabolism. Ed. H.H. Munro. Academic Press, New York, 1969. pp. 21-132.
81. Jumaa P, Wren B and Tabaqchali S. Epidemiology and typing of Clostridium difficile. European Journal of Gastroenterology and Hepatology 1996; 8: 1035-1040.
82. Just I, Hofmann F and Aktories K. Molecular mode of action of the large clostridial cytotoxins. In: Clostridium difficile. 1st edn. Eds: K. Aktories and T.D. Wilkins. Springer, Berlin, 2000. pp. 55-83.
83. Karasawa T, Nojiri T, Hayashi Y, Maegawa T, Yamakawa K, Wang XM and Nakamura S. Laboratory diagnosis of toxigenic Clostridium difficile by polymerase chain reaction; presence of toxin genes and their stable expression in toxigenic isolates from Japanese individuals. Journal of Gastroenterology 1999; 34: 41-45.
84. Kato N, Ou CY, Kato H, Bartley S, Brown VK, Dowell VR Jr and Ueno K. Identification of toxigenic Clostridium difficile by the polymerase chain reaction. Journal of Clincal Microbiology 1991; 29: 33-37.
85. Kato N, Ou CY, Kato H, Bartley SL, Luo CC, Killgore GE and Ueno K. Detection of toxigenic Clostridium difficile in stool specimens by the polymerase chain reaction. The Journal of Infectious Diseases 1993; 167: 455-458.
86. Kato H, Kato N, Watanabe K, Iwai N, Nakamura H, Yamamoto T, Suzuki K, Kim S-M, Chong Y and Wasito EB. Identification of toxin A-negative, toxin B-positive Clostridium difficile by PCR. Journal of Clinical Microbiology 1998; 36: 2178-2182.
87. Kelly CP and LaMont JT. Clostridium difficile infection. Annual Review of Medicine 1998; 49: 375-390.
88. Kelly CP, Pothoulakis C and LaMont JT. Clostridium difficile colitis. New England Journal of Medicine 1994; 330: 257-262.
89. Killgore GE and Kato H. Use of arbitrary primer PCR to type Clostridium difficile and comparison of results with those by immunoblot typing. Journal of Clinical Microbiology 1994; 32: 1591-1593.
90. Kim K-H, Fekety R, Batts DH, Brown D, Cudmore M, Silva J Jr and Waters D. Isolation of Clostridium difficile from the environment and contacts of patients with antibiotic-associated colitis. Journal of Infectious Diseases 1981; 143: 42-50.
91. Klaassen CHW, van Haren HA and Horrevorts AM. Molecular fingerprinting of Clostridium difficile isolates: pulsed-field gel electrophoresis versus amplified fragment length polymorphism. Journal of Clinical Microbiology 2002; 40: 101-104.
92. Kristjánsson M, Samore MH, Gerding DN, DeGirolami PC, Bettin KM, Karchmer AW and Arbeit RD. Comparison of restiction endonuclease analysis, ribotyping, and pulsed-field gel electrophoresis for molecular differentiation of Clostridium difficile strains. Journal of Clinical Microbiology 1994; 32: 1963-1969.
93. Larson HE, Price AB, Honour P and Borriello SP. Clostridium difficile and the aethiology of pseudomembranous colitis. Lancet i, 1978; 1063-1066.
94. Larson HE, Barclay FE, Honour P and Hill ID. Epidemiology of Clostridium difficile in infants. Journal of Infectious Diseases 1982; 146: 727-733.
95. Levert PN. Use of enrichment cultures for the isolation of Clostridium difficile from stools. Microbios Letters 1984; 25: 67-69.
96. Levett PN. Effect of antibiotic concentration in a selective medium on the isolation of Clostridium difficile from faecal specimens. Journal of Clinical Pathology 1985; 38: 233-234.
97. Lyerly DM. Clostridium difficile testing. Clinical Microbiology Newsletter 1995; 17: 17-22.
98. Lyerly DM, Lockwood DE, Richardson SH and Wilkins TD. Biological activities of toxins A and B of Clostridium difficile. Infection and Immunity 1982; 35: 1147-1150.
99. Lyerly DM, Saum KE, MacDonald DK and Wilkins TD. Effects of Clostridium difficile toxins given intragastrically to animals. Infection and Immunity 1985; 47: 349-352.
100. Lyerly DM, Krivan HC and Wilkins TD. Clostridium difficile: Its disease and toxins. Clinical Microbiology Reviews 1988; 1: 1-18.
101. Lyerly DM, Neville LM, Evans DT, Fill J, Allen S, Greene W, Sautter R, Hnatuck P, Torpey DJ and Schwalbe R. Multicenter evaluation of the Clostridium difficile TOX A/B test. Journal of Clinical Microbiology 1998; 36: 184-190.
102. Madewell BR, Tang YJ, Jang S, Madigan JE, Hirsh DC, Gumerlock PH and Silva J. Apparent outbreak of Clostridium difficile-associated diarrhea in horses in a veterinary medical teaching hospital. Journal of Veterinary Diagnostic Investigation 1995; 7: 343-346.
103. Madewell BR, Bea JK, Kraegel SA, Winthrop M, Tang YJ and Silva J Jr. Clostridium difficile: a survey of fecal carriage in cats in a veterinary medical teaching hospital. Journal of Veterinary Diagnostic Investigation 1999: 11: 50-54.
104. Magdesian KG, Madigan JE, Hirsh DC, Jang SS, Tang YJ, Carpenter TE, Hansen LM and Silva J Jr. Clostridium difficile and horses: a review. Reviews in Medical Microbiology 1997; 8 (Suppl 1): S46-S48.
105. Magdesian KG, Hirsh DC, Jang SS and Madigan JE. Characterisation of Clostridium difficile isolates from an outbreak of enteritis in neonatal foals. In: Proc. 8th International Conference on Equine Infectious Diseases, Dubai, 23-26 March, 1998. 1st edn. Eds. U. Wernery, J.F. Wade, J.A. Mumford and O.-R. Kaaden. R and W Publications (Newmarket) Limited. pp. 561-562.
106. Magdesian KG, Hirsh D C, Jang SS, Hansen LM and Madigan JE. Characterization of Clostridium difficile isolates from foals with diarrhea: 28 cases (1993-1997) Journal of the American Veterinary Medical Association 2002; 220: 67-73.
107. Mair TS, de Westerlaken LV, Cripps PJ and Love S. Diarrhoea in adult horses: A survey of clinical cases and an assessment of some prognostic indices. Veterinary Record 1990; 126: 479-481.
108. Malmqvist M, Jacobsson K-G, Häggblom P, Cerenius F, Sjöland L and Gunnarsson A. Salmonella isolation from animals and feedstuffs in Sweden during 1988-1992. Acta Veterinaria Scandinavica 1995; 36: 21-39.
109. Martirossian G, Sokol-Leszcynska B, Mierzejewski J and Meisel-Mikolajczyk F. Occurence of Clostridium difficile in the digestive system of dogs. Medycyna Doswiadczalna i Mikrobiologia 1992; 44: 49-54.
110. Mayfield JL, Leet T, Miller J and Mundy MM. Environmental control to reduce transmission of Clostridum difficile. Infection Control and Hospital Epidemiology 2000; 31: 995-1000.
111. McFarland LV, Mulligan ME, Kwok RYY and Stamm WE. Nosocomial acquisition of Clostridium difficile infection. New England Journal of Medicine 1989; 4: 204-210.
112. McFarland LV, Surawicz CM and Stamm WE. Risk factors for Clostridium difficile carriage and C. difficile-associated diarrhea in a cohort of hospitalized patients. Journal of Infectious Diseases 1990; 162: 678-684.
113. McGowan KL and Kader HA. Clostridium difficile infection in children. Clinical Microbiology Newsletter 1999; 21: 49-53.
114. McMillan D, Muldrow L and Laggette S. Simultaneous detection of toxin A and toxin B genetic determinants of Clostridium difficile using the multiplex polymerase chain reaction. Canadian Journal of Microbiology 1992; 38: 81-83.
115. Melcher SA and Moyer KA. Clostridium difficile-associated disease. Clinician Reviews 1995; 5: 75-92.
116. Merida V, Moerman J, Colaert J, Lemmens P and Vandepitte J. Significance of Clostridium difficile and its cytotoxin in children. European Journal of Pediatrics 1986; 144: 494-496.
117. Mitty RD and LaMont JT. Clostridium difficile diarrhea; pathogenesis, epidemiology and treatment. Gastroenterologist 1994; 2: 61-69.
118. Möllby R, Nord CE and Aronsson B. Diagnosis of Clostridium difficile-associated enterocolitis in Sweden. Laboratory and epidemiological aspects. Scandinavian Journal of Infectious Diseases 1980; Suppl 22: 30-36.
119. Möllby R, Aronsson B and Nord CE. Pathogenisis and diagnosis of Clostridium difficile enterocolitis. Scandinavian Journal of Infectious Diseases 1985; Suppl 46: 47-56.
120. Moncrief JS and Wilkins TD. Genetics of Clostridium difficile toxins. In: Clostridium difficile. 1st edn. Eds. K. Aktories and T.D. Wilkins. Springer, Berlin, 2000. pp.35-54.
121. Mulligan ME, Rolfe RD, Finegold SM and George WL. Contamination of hospital environment by Clostridium difficile. Current Microbiology 1979; 3: 173-175.
122. Murray MJ. Acute colitis. In: Current Therapy in Equine Medicine 3, 1st edn. Ed. N.E. Robinson. W.B. Saunders Company, Philadelphia, 1992. pp. 244-250.
123. Nakamura S, Mikawa M, Nakashio S, Takabatake M, Okada I and Yamakawa K. Isolation of Clostridium difficile from feces and the antibody in sera of young and elderly adults. Microbiology and Immunology 1981; 25: 345-351.
124. Nakamura S, Nakashio S, Mikawa M, Yamakawa K, Okumura S and Nishida S. Antimicrobial susceptibility of Clostridium difficile from different sources. Microbiology and Immunology 1981; 26: 25-30.
125. Ochoa R and Kern SR. The effects of Clostridium perfringens type A enterotoxin in Shetland ponies. Clinical, morphologic and clinicopathologic changes. Veterinary Pathology 1980; 17: 738-747.
126. O'Connor D, Hynes P, Cormican M, Collins E, Corbett-Feeney G and Cassidy M. Evaluation of methods for detection of toxins in specimens of feces submitted for diagnosis of Clostridium difficile-associated diarrhea. Journal of Clinical Microbiology 2001; 39: 2846-2849.
127. O'Neill GL, Ogunsola FT, Brazier JS and Duerden BI. Modification of a PCR ribotyping method for application as a routine typing scheme for Clostridium difficile. Anaerobe 1996; 2: 205-209.
128. Palmer JE. Diarrhea. In: Veterinary Gastroenterology, 2nd edn. Ed. N.V. Anderson. Lea and Febiger, Philadelphia, 1992. pp. 646-654.
129. Perrin J, Cosmetatos I, Gallusser A, Lobsiger L, Straub R and Nicolet J. Clostridium difficile associated with typhlocolitis in an adult horse. Journal of Veterinary Diagnostic Investigation 1993; 5: 99-101.
130. Perrin J, Buogo C, Gallusser A, Burnens AP and Nicolet J. Intestinal carriage of Clostridium difficile in neonate dogs. Journal of Veterinary Medicine B 1993; 40: 222-226.
131. Prescott JF, Staempfli HR, Barker IK, Bettoni R and Delaney K. A method for reproducing fatal idiopathic colitis (colitis x) in ponies and isolation of a clostridium as a possible agent. Equine Veterinary Journal 1988; 20: 417-420.
132. Priest F and Austin B. Modern Bacterial Taxonomy. Chapman and Hall, London, UK, 1993.
133. Quinn PJ, Carter ME, Markey B and Carter GR. Clostridium species. In: Clinical Veterinary Microbiology. Wolfe Publishing, Mosby-Year Book Europe Limited, London, 1994. pp 191-208.
134. Raisbeck MF, Holt GF and Osweiler GD. Lincomycin-associated colitis in horses. Journal of the American Veterinary Medical Association 1981; 179: 362-363.
135. Rehg JE and Lu Y-S. Clostridium difficile in a rabbit following antibiotic therapy for pasteurellosis. Journal of the American Veterinary Medical Association 1981; 179: 1296-1297.
136. Rehg JE and Pakes SP. Clostridium difficile antitoxin neutralization of cecal toxin(s) from guinea pigs with penicillin-associated colitis. Laboratory Animal Science 1981; 31: 156-160.
137. Riegler M, Sedivy R, Pothoulakis C, Hamilton G, Zacherl J, Bischof G, Cosentini E, Feil W, Schiessel R and LaMont JT. Clostridium difficile toxin B is more potent than toxin A in damaging human colonic epithelium in vitro. Journal of Clinical Investigation 1995; 95: 2004-2011.
138. Riley TV, Adams JE, O'Neill GL and Bowman RA. Gastrointestinal carriage of Clostridium difficile in cats and dogs attending veterinary clinics. Epidemiology and Infection 1991; 107: 659-665.
139. Rothman SW. Presence of Clostridium difficile toxin in guinea pigs with penicillin-associated colitis. Medical Microbiology and Immunology 1981; 169: 187-196.
140. Rupnik M. How to detect Clostridium difficile variant strains in a routine laboratory. Clinical Microbiology and Infection 2001; 7: 417-420.
141. Rupnik M, Brazier JS, Duerden BI, Grabnar M and Stubbs SLJ. Comparison of toxinotyping and PCR ribotyping of Clostridium difficile strains and description of novel toxinotypes. Microbiology 2001; 147: 439447.
142. Rupnik M, Avesani V, Janc M, von Eichel-Streiber C and Delmée M. A novel toxinotyping scheme and correlation of toxinotypes with serogroups of Clostridium difficile isolates. Journal of Clinical Microbiology 1998; 36: 2240-2247.
143. Sage R. Nosocomial infections: listening to human experience may help the horse. Equine Veterinary Journal 1998; 30: 450-451.
144. Saitou N and Nei M. The neighbor-joining method: a new method for reconstructing phylogenetic trees. Molecular Biology and Evolution 1987; 4: 406-25.
145. Samore MH, Kristjansson M, Venkataraman L, DeGirolami PC and Arbeit RD. Comparison of arbitrarily-primed polymerase chain reaction, restiction enzyme analysis and pulsed-field gel electrophoresis for typing Clostridium difficile. Journal of Microbiological Methods 1996; 25: 215-224.
146. Silva S. Clostridium difficile nosocomial infections - still lethal and persistant. Infection Control and Hospital Epidemiology 1994; 15: 368-370.
147. Silva J Jr, Tang YJ and Gumerlock PH. Genotyping of Clostridium difficile isolates. The Journal of Infectious Diseases 1994; 169: 661-664.
148. Smith BP. Salmonellosis. In: Large Animal Internal Medicine, 1st edn. St. Louis, CV Mosby Co, 1991. pp 818-822.
149. Snyder ML. The normal fecal flora of infants between two weeks and one year of age. I. Serial studies. Journal of Infectious Diseases 1940; 66: 1-16.
150. Spencer RC. Clinical impact and associated costs of Clostridium difficile-associated disease. Journal of Antimicrobial Chemotherapy 1998; 41, Suppl. C: 5-12.
151. Spencer RC. The role of antimicrobial agents in the aethiology of Clostridium difficile-associated disease, Journal of Antimicrobial Chemotherapy 1998; 41, Suppl. C: 21-27.
152. Stackebrandt E and Rainey FA. Phylogenetic relationships. In: The Clostridia Molecular Biology and Pathogenesis. 1st edn. Eds. J.I. Rood, B.A. McClane, Songer JG and R.W. Titball. Academic Press, San Diego, California. 1997.
153. Staempfli HR, Townsend HGG and Prescott JF. Prognostic features and clinical presentation of acute idiopathic enterocolitis in horses. Canadian Veterinary Journal 1991; 32: 232-237.
154. Staempfli HR, Prescott JF and Brash ML. Lincomycin-induced severe colitis in ponies: Association with Clostridium cadaveris. Canadian Journal of Veterinary Research 1992; 56: 168-169.
155. Struble AL, Tang YJ, Kass PH, Gumerlock PH, Madewell BR and Silva J Jr. Fecal shedding of Clostridium difficile in dogs: a period prevalence survey in a veterinary medical teaching hospital. Journal of Veterinary Diagnostic Investigation 1994; 6: 342-347.
156. Stubbens DP. Clostridium perfringens enterotoxaemia in two young horses. Veterinary Record 1990; 127: 431.
157. Stubbs SLJ, Brazier JS, O'Neill GL and Duerden BI. PCR targeted to the 16S-23S rRNA gene intergenic spacer region of Clostridium difficile and construction of a library consisting of 116 different PCR ribotypes. Journal of Clinical Microbiology 1999; 37: 461-463.
158. Stubbs S, Rupnik M, Gibert M, Brazier J, Duerden B and Popoff M. Production of actin-specific ADP-ribosyltransferase (binary toxin) by strains of Clostridium difficile. FEMS Microbiology Letters 2000; 186: 307-312.
159. Tabaqchali S and Jumaa P. Diagnosis and management of Clostridium difficile infection. British Medical Journal 1995; 310: 1375-1380.
160. Tang YJ, Houston ST, Gumerlock PH, Mulligan ME, Gerding DN, Johnson S, Fekety FR and Silva J Jr. Comparison of arbitrarily primed PCR with restriction endonuclease and immunoblot analyses for typing Clostridium difficile isolates. Journal of Clinical Microbiology 1995; 33: 3169-3173.
161. Tedesco FJ, Barton RW and Alpers DH. Clindamycin-associated colitis. Annals of Internal Medicine 1974; 81: 429-433.
162. Thelestam M and Chaves-Olarte E. In: Clostridium difficile. 1st edn. Eds. K. Aktories and T.D. Wilkins. Springer, Berlin, 2000. pp. 85-96.
163. TIGR Microbial Database, 2002. TIGR, The Institute for Genomic Research. Rockville, MD, USA. (http: //www.tigr.org/tdb/mbd/mdbinprogress.html, accessed April, 15, 2002).
164. Traub-Dargatz JL and Jones RL. Clostridia-associated enterocolitis in adult horses and foals. The Veterinary Clinics of North America. Equine Practice 1993; 9: 411-421.
165. Tullus K, Aronsson B, Marcus S and Möllby R. Intestinal colonization with Clostridium difficile in infants up to 18 months of age. European Journal of Clinical Microbiology and Infectious Diseases 1989; 8: 390-393.
166. Vandamme P, Pot B, Gillis M, De Vos P, Kersters K and Swings J. Polyphasic taxonomy, a consensus approach to bacterial systematics. Microbiological Reviews 1996; 60: 407-438.
167. Vaughan JT. The acute colitis syndrome. Colitis X. The Veterinary Clinics of North America 1973; 3: 301-313.
168. Vollaard EJ and Clasener HAL. Colonization resistance. Antimicrobial Agents and Chemotherapy 1994; 38: 409-414.
169. Waters EH, Orr JP, Clark EG and Schaufele CM. Typhlocolitis caused by Clostridium difficile in suckling piglets. Journal of Veterinary Diagnostic Investigation 1998; 10: 104-108.
170. Weber A, Kroth P and Heil G. Occurrence of Clostridium difficile in fecal samples of dogs and cats. Zentralblatt für Veterinärmedicin [B] 1989; 36: 568-76.
171. Weese JS, Staempfli HR and Prescott JF. Isolation of environmental Clostridium difficile from a veterinary teaching hospital. Journal of Veterinary Diagnostic Investigation 2000; 12, 449-452.
172. Weese JS, Staempfli HR and Prescott JF. Survival of Clostridium difficile and its toxins in equine faeces. Journal of Veterinary Diagnostic Investigation 2000; 12: 332-336.
173. Weese JS, Staempfli HR and Prescott JF. A prospective study of the roles of Clostridium difficile and enterotoxigenic Clostridium perfringens in equine diarrhoea. Equine Veterinary Journal 2001; 33: 403-409.
174. Weese JS, Staempfli HR, Prescott JF, Kruth SA, Greenwood SJ and Weese HE. The roles of Clostridium difficile and enterotoxigenic Clostridium perfringens in diarrhea in dogs. Journal of Veterinary Internal Medicine 2001; 15: 374-378.
175. Wierup M. Equine intestinal clostridiosis, an acute disease of horses associated with high intestinal counts of Clostridium perfringens type A. Acta Veterinaria Scandinavica 1977; Supplementum 62: 1-182.
176. Wilson KH, Kennedy MJ and Fekety FR. Use of sodium taurocholate to enhance spore recovery on a medium selective for Clostridium difficile. Journal of Clinical Microbiology 1982; 15: 443-446.
177. Wolfhagen MJ, Fluit AC, Torensma R, Poppelier MJ and Verhoef J. Rapid detection of toxigenic Clostridium difficile in fecal samples by magnetic immuno-PCR assay. Journal of Clinical Microbiology 1994; 32: 1629-33.
178. Wong SS, Woo PC, Luk WK and Yuen KY. Susceptibility testing of Clostridium difficile against metronidazole and vancomycin by disk diffusion and Etest. Diagnostic Microbiology and Infectious Disease 1999; 34: 1-6.
179. Worsley MA. Infection control and prevention of Clostridium difficile infection. Journal of Antimicrobial Chemotherapy 1998; 41, Suppl. C: 59-66.
180. Wren B, Clayton C and Tabaqchali S. Rapid identification of toxigenic Clostridium difficile by polymerase chain reaction. Lancet 1990; 335: 423.
181. Wüst J and Hardegger U. Studies on the resistance of Clostridium difficile to antimicrobial agents. Zentralblatt für Bakteriologie, Mikrobiologie, und Hygiene A 1988; 267: 383-394.